Search Results 411-420 of 17379 for Oncogene

1. Clinical trials - Oncology (Medical)

   Rochester, Minn. This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or ...

2. A Study To Compare The Combination Of BMS-986504 With Pembrolizumab And Chemotherapy Versus Placebo Plus Pembrolizumab And Chemotherapy In First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion - Mayo Clinic

   * Nonsquamous participants must not have documented targetable oncogenic mutation or actionable genetic alterations (AGAs) for which there is a standard of ...

3. Steven S. Rosenfeld, M.D., Ph.D. - Mayo Clinic Faculty Profiles

   Rosenfeld's lab has shown that glioblastomas consist of subpopulations of tumor cells that depend on different oncogenic kinases, with each subpopulation ...

4. A Study Of BH-30643 In Subjects With Locally Advanced Or Metastatic NSCLC Harboring EGFR And/or HER2 Mutations - Mayo Clinic

   * Known other oncogenic driver alterations (eg, moderate or high MET amplification) or histological transformation (eg, to small cell carcinoma, etc.).

5. Publications - Craig M. Horbinski, M.D., Ph.D. - Mayo Clinic

   Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis. Neuro Oncol. 2023 Sep 5; 25 (9): ...

6. Mutations in Epigenetic Regulator Genes as Drivers of Cancer - Research

   This diagram illustrates epigenetic writers, readers and erasers of histone H3 lysine 36 methylation, their links to human disease and cancer, ...

7. Cancer Biology and Translational Research - Establishment and Characterization of New Preclinical Models

   The Copland Cancer Biology and Translational Research Lab is creating validated cell lines and PDTX models to pave the way for better cancer treatment.

8. Clinical trials - Oncology (Medical)

   Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

9. Clinical trials - Oncology (Medical)

   This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

10. A Global Phase III Study Of Rilvegostomig Or Pembrolizumab Plus Chemotherapy For First-Line Treatment Of Metastatic Non-squamous NSCLC - Mayo Clinic

    * Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any other actionable driver oncogenes for ...